{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06350175",
            "orgStudyIdInfo": {
                "id": "2212697123"
            },
            "organization": {
                "fullName": "West Virginia University",
                "class": "OTHER"
            },
            "briefTitle": "Emergency Department Management of Tobacco Use Disorder",
            "officialTitle": "Emergency Department Based Management of Tobacco Use Disorder",
            "therapeuticArea": [
                "Other"
            ],
            "study": "emergency-department-management-of-tobacco-use-disorder"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-06",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-01",
            "studyFirstSubmitQcDate": "2024-04-01",
            "studyFirstPostDateStruct": {
                "date": "2024-04-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Bradley End",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "West Virginia University"
            },
            "leadSponsor": {
                "name": "West Virginia University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this study is to determine the effectiveness of ED initiated NRT on tobacco cessation point abstinence rates as reported by patients at 2 weeks and 1 month post randomization, and continued abstinence rates at 3 months compared to standard of care therapy."
        },
        "conditionsModule": {
            "conditions": [
                "Tobacco Use Disorder",
                "Tobacco Use Cessation"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Nicotine Replacement Therapy (NRT)",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Subject provided with a 2-week supply of NRT and a West Virginia Quit Line (WV QL) fact sheet/contact information.",
                    "interventionNames": [
                        "Combination Product: Nicotine Replacement Therapy Agent",
                        "Other: West Virginia Quit Line"
                    ]
                },
                {
                    "label": "Control Non NRT Therapy",
                    "type": "OTHER",
                    "description": "Subject will be provided with a box/bag containing a WV QL fact sheet/contact information.",
                    "interventionNames": [
                        "Other: West Virginia Quit Line"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Nicotine Replacement Therapy Agent",
                    "description": "The NRT Agents-- 21mg nicotine patches (x14) and 2 mg nicotine lozenges (\\~210).",
                    "armGroupLabels": [
                        "Nicotine Replacement Therapy (NRT)"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "West Virginia Quit Line",
                    "description": "Instructional Pamphlets and contact information for the WV QL. A telehealth line set up to assist people of WV to quit smoking.",
                    "armGroupLabels": [
                        "Control Non NRT Therapy",
                        "Nicotine Replacement Therapy (NRT)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Continued Abstinence Rate (2 weeks)",
                    "description": "Percentage of subjects who self-report continued abstinence in tobacco use at 2 weeks from initial dose given during the ED visit.",
                    "timeFrame": "2 Weeks post initial dose"
                },
                {
                    "measure": "Percentage of Continued Abstinence Rate (1 month)",
                    "description": "Percentage of subjects who self-report continued abstinence in tobacco use at 1 month from initial dose given during the ED visit.",
                    "timeFrame": "1 Month post initial dose"
                },
                {
                    "measure": "Percentage of Continued Abstinence Rate (3 months)",
                    "description": "Percentage of subjects who self-report continued abstinence in tobacco use at 3 months from initial dose given during the ED visit.",
                    "timeFrame": "3 Months post initial dose"
                },
                {
                    "measure": "Patient Health Questionnaire 2 (Baseline)",
                    "description": "A validated instrument to assess the frequency of depression and anhedonia screen for depression, scores can range from 0 to 6, with each item scored from 0 (not at all) to 3 (nearly every day). Scores greater than or equal to typically indicate depression.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Patient Health Questionnaire 2 (3 months from baseline)",
                    "description": "A validated instrument to assess the frequency of depression and anhedonia screen for depression, scores can range from 0 to 6, with each item scored from 0 (not at all) to 3 (nearly every day). Scores greater than or equal to typically indicate depression.",
                    "timeFrame": "3 months from baseline"
                },
                {
                    "measure": "Heaviness of Smoking Index (Baseline)",
                    "description": "A validated measure used to determine the level of nicotine addiction, with a scale of 0-6 (3 indicates moderate addiction, \\>5 is severe)",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Heaviness of Smoking Index (3 months from baseline)",
                    "description": "A validated measure used to determine the level of nicotine addiction, with a scale of 0-6 (3 indicates moderate addiction, \\>5 is severe)",
                    "timeFrame": "3 months from baseline"
                },
                {
                    "measure": "Richmond Test (Baseline)",
                    "description": "A validated instrument to assess motivation to quit smoking. This is scored on a 0-10 scale with 5-6 indicating moderate motivation to quit and 7+ indicating strong motivation to quit.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Richmond Test (3 months from baseline)",
                    "description": "A validated instrument to assess motivation to quit smoking. This is scored on a 0-10 scale with 5-6 indicating moderate motivation to quit and 7+ indicating strong motivation to quit.",
                    "timeFrame": "3 months from baseline"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Current daily use cigarettes greater than or equal to \u00bd pack per day\n* Stable for discharge from the ED\n* Able and willing to complete telephone/electronic follow up at scheduled intervals\n* Reported English speaking\n\nExclusion Criteria:\n\n* Patients enrolled in specific health insurance plans (PEIA, The Health Plan or Medicaid medical insurance)\n* WVU students\n* Medically unstable patients\n* Patients with clinical decompensation or who are admitted to the hospital\n* Patients who are discharged to residential treatment facilities for detoxification\n* Uncontrolled psychiatric disorder or psychiatric emergency\n* Individuals who are unable to provide consent\n* Incarcerated individuals\n* Language barrier\n* Currently pregnant or attempting to become pregnant\n* Presenting for evaluation of sexual assault\n* Known allergy or previous intolerance to nicotine replacement therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "70 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Bradley End, MD",
                    "role": "CONTACT",
                    "phone": "304 293 9565",
                    "email": "bradley.end@hsc.wvu.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Bradley End",
                    "affiliation": "West Virginia University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "West Virginia University",
                    "city": "Morgantown",
                    "state": "West Virginia",
                    "zip": "26505",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.62953,
                        "lon": -79.9559
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014029",
                    "term": "Tobacco Use Disorder"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7796",
                    "name": "Emergencies",
                    "relevance": "LOW"
                },
                {
                    "id": "M16785",
                    "name": "Tobacco Use Disorder",
                    "asFound": "Tobacco Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009538",
                    "term": "Nicotine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005731",
                    "term": "Ganglionic Stimulants"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018722",
                    "term": "Nicotinic Agonists"
                },
                {
                    "id": "D000018679",
                    "term": "Cholinergic Agonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "asFound": "Assess",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20796",
                    "name": "Nicotinic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                }
            ]
        }
    },
    "hasResults": false
}